Novosti
Khirurgii
This journal is
indexed in Scopus









Year 2015 Vol. 23 No 3

REVIEWS

DOI: http://dx.doi.org/10.18484/2305-0047.2015.3.339   |  

I.V. MAIBORODIN, 1, S.E. KRASILNIKOV2, A.E. KOZJAKOV2, E.V. BABAYANTS2, A.P. KULIDZHANYAN2

THE FEASIBILITY OF TUMOR-RELATED ANGIOGENESIS STUDY AS A PROGNOSTIC FACTOR FOR CANCER DEVELOPMENT

FSBES "Institute of Chemical Biology and Fundamental Medicine", of SB of RAS, Novosibirsk1,
SBEE HPE "Novosibirsk State Medical University" 2
The Russian Federation

Objectives. To study a scientific literature review devoted to tumor-related angiogenesis and peculiarities of malignant tumors vascularization.
Methods. The analysis of about 50 foreign literature publications has been carried out.
Results. Numerous and often inconsistent results of studies specify that vascularization of malignant tumors can be considered to be an independent prognostic factor of a cancer progression, its invasion, appearance of local and distant metastases. Also there are a lot of publications calling into question a significance of the tumor angiogenesis as a predictor of tumor aggressiveness. The existence of the questionable publications containing statistically doubtful data with the improper interpretation of the received results should be mentioned. Only a few papers indirectly devoted to an angiogenesis in the distant organs and tissues were found.
Conclusion. The changes of tumor vascularization happen as a result of influence of various factors and releases produced by both cancerous cells and surrounding tissues at their hypoxia. All these cytokines and, partially, cellular elements are disseminated throughout the whole body and also have to manifest their pro- and antiangiogenic effect in the distant organs and tissues. Therefore, studying of angiogenesis in the places, distant from a tumor node, determination and specification of the predictors of intensity of a cancer progression and appearance of metastases, effectiveness of treatment and prospect of recurrence seems to be expedient. It is not excluded that analyzing vascularization changes, (for example, a skin), the prediction of angiogenesis intensity in the primary tumor and assessment of the main pathology prediction and effectiveness of the treatment will be possible in future.

Keywords: angiogenesis, pathology, hypoxia, tumor vascularization, prognostic factors of cancer progression, effectiveness of the treatment, recurrence
p. 339-347 of the original issue
References
  1. Alcalde RE, Terakado N, Otsuki K, Matsumura T.Angiogenesis and expression of platelet-derived endothelial cell growth factor in oral squamous cell carcinoma. Oncology. 1997 Jul-Aug;54(4):324-8.
  2. Farnsworth RH, Lackmann M, Achen MG, Stacker SA. Vascular remodeling in cancer. Oncogene. 2014 Jul 3;33(27):3496-505. doi: 10.1038/onc.2013.304.
  3. Kaku T, Kamura T, Kinukawa N, Kobayashi H, Sakai K, Tsuruchi N, Saito T, Kawauchi S, Tsuneyoshi M, Nakano H.Angiogenesis in endometrial carcinoma. Cancer. 1997 Aug 15;80(4):741-7.
  4. Sauter ER, Nesbit M, Watson JC, Klein-Szanto A, Litwin S, Herlyn M. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck. Clin Cancer Res. 1999 Apr;5(4):775-82.
  5. Choi HJ, Hyun MS, Jung GJ, Kim SS, Hong SH. Tumor angiogenesis as a prognostic predictor in colorectal carcinoma with special reference to mode of metastasis and recurrence. Oncology. 1998 Nov-Dec;55(6):575-81.
  6. Ben Q, Zheng J, Fei J, An W, Li P, Li Z, Yuan Y.High neuropilin 1 expression was associated with angiogenesis and poor overall survival in resected pancreatic ductal adenocarcinoma.
  7. Yan Y1, Shen Z, Ye Y, Jiang K, Zhang H, Shen C, Mustonen H, Puolakkainen P, Wang S. A novel molecular marker of prognosis in colorectal cancer: Vasohibin-1. Pancreas. 2014 Jul;43(5):744-9. doi: 10.1097/MPA.0000000000000117.
  8. Grigore D, Simionescu CE, Stepan A, Mărgăritescu C, Bălăşoiu M, Georgescu CC, Cernea D, Dumitrescu D. Assessment of CD105, α-SMA and VEGF expression in gastric carcinomas. Rom J Morphol Embryol. 2013;54(3 Suppl):701-7.
  9. Ren J, Xu S, Guo D, Zhang J, Liu S.Increased expression of α5β1-integrin is a prognostic marker for patients with gastric cancer. Clin Transl Oncol. 2014 Jul;16(7):668-74. doi: 10.1007/s12094-013-1133-y.
  10. Tjalma W, Van Marck E, Weyler J, Dirix L, Van Daele A, Goovaerts G, Albertyn G, van Dam P. Quantification and prognostic relevance of angiogenic parameters in invasive cervical cancer. Br J Cancer. 1998 Jul;78(2):170-4
  11. Chen J, Wei D, Zhao Y, Liu X, Zhang J. Overexpression of EFEMP1 correlates with tumor progression and poor prognosis in human ovarian carcinoma. PLoS One. 2013 Nov 13;8(11):e78783. doi: 10.1371/journal.pone.0078783. eCollection 2013.
  12. Yu TT, Han ZG, Shan L, Tao J, Zhang T, Yuan SF, Shen HL. Expression of osteopontin in non-small cell lung cancer and correlative relation with microvascular density. Asian Pac J Cancer Prev. 2014;15(1):29-32.
  13. Tanaka T, Sho M, Takayama T, Wakatsuki K, Matsumoto S, Migita K, Ito M, Hamada K, Nakajima Y. Endothelin B receptor expression correlates with tumour angiogenesis and prognosis in oesophageal squamous cell carcinoma. Br J Cancer. 2014 Feb 18;110(4):1027-33. doi: 10.1038/bjc.2013.784.
  14. Xu Q, Gao S, Liu J. [The expression of caspase-3, bFGF and MVD in laryngeal squamous cell carcinoma and the relationship among them]. [Article in Chinese] Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2013 Oct;27(19):1084-7.
  15. Irani S, Salajegheh A, Gopalan V, Smith RA, Lam AK. Expression profile of endothelin 1 and its receptor endothelin receptor A in papillary thyroid carcinoma and their correlations with clinicopathologic characteristics. Ann Diagn Pathol. 2014 Apr;18(2):43-8. doi: 10.1016/j.anndiagpath.2013.11.001.
  16. Dębiński P, Dembowski J, Kowal P, Szydełko T, Kołodziej A, Małkiewicz B, Tupikowski K, Zdrojowy R. The clinical significance of lymphangiogenesis in renal cell carcinoma. Med Sci Monit. 2013 Jul 24;19:606-11. doi: 10.12659/MSM.883981.
  17. Ni X, Zhao Y, Ma J, Xia T, Liu X, Ding Q, Zha X, Wang S. Hypoxia-induced factor-1 alpha upregulates vascular endothelial growth factor C to promote lymphangiogenesis and angiogenesis in breast cancer patients. J Biomed Res. 2013 Nov;27(6):478-85. doi: 10.7555/JBR.27.20130021.
  18. Haisan A, Rogojanu R, Croitoru C, Jitaru D, Tarniceriu C, Danciu M, Carasevici E. Digital microscopy assessment of angiogenesis in different breast cancer compartments. Biomed Res Int. 2013;2013:286902. doi: 10.1155/2013/286902.
  19. D'Ovidio MC, Mastracchio A, Marzullo, Ciabatta M, Pini B, Uccini S, Zardi L, Ruco LP. Intratumoral microvessel density and expression of ED-A/ED-B sequences of fibronectin in breast carcinoma. Eur J Cancer. 1998 Jun;34(7):1081-85.
  20. Sikora J, Słodkowska J, Radomyski A, Giedronowicz D, Kobos J, Kupis W, Rudzinski P. Immunohistochemical evaluation of tumour angiogenesis in adenocarcinoma and squamous cell carcinoma of lung. Rocz Akad Med Bialymst. 1997;42 Suppl 1:271-79.
  21. Bing Z, Jian-ru Y, Yao-quan J, Shi-feng C.Evaluation of angiogenesis in non-small cell lung carcinoma by CD34 immunohistochemistry. Cell Biochem Biophys. 2014 Sep;70(1):327-31. doi: 10.1007/s12013-014-9916-5.
  22. Tomoda M, Maehara Y, Kakeji Y, Ohno S, Ichiyoshi Y, Sugimachi K.Intratumoral neovascularization and growth pattern in early gastric carcinoma. Cancer. 1999 Jun 1;85(11):2340-46.
  23. Thielemann A, Baszczuk A, Kopczyński Z, Kopczyński P, Grodecka-Gazdecka S. Clinical usefulness of assessing VEGF and soluble receptors sVEGFR-1 and sVEGFR-2 in women with breast cancer. Ann Agric Environ Med. 2013;20(2):293-97.
  24. Abbasi MM, Monfaredan A, Hamishehkar H, Seidi K, Jahanban- Esfahlan R.Novel DOX-MTX nanoparticles improve oral SCC clinical outcome by down regulation of lymph dissemination factor VEGF-C expression in vivo: oral and IV modalities. Asian Pac J Cancer Prev. 2014;15(15):6227-32.
  25. Kodama J, Seki N, Tokumo K, Hongo A, Miyagi Y, Yoshinouchi M, Okuda H, Kudo T.Vascular endothelial growth factor is implicated in early invasion in cervical cancer. Eur J Cancer. 1999 Mar;35(3):485-89.
  26. Yang ZS, Xu YF, Huang FF, Ding GF. Associations of nm23H1, VEGF-C, and VEGF-3 receptor in human prostate cancer. Molecules. 2014 May 23;19(5):6851-62. doi: 10.3390/molecules19056851.
  27. Srabovic N, Mujagic Z, Mujanovic-Mustedanagic J, Softic A, Muminovic Z, Rifatbegovic A, Begic L. Vascular endothelial growth factor receptor-1 expression in breast cancer and its correlation to vascular endothelial growth factor a. Int J Breast Cancer. 2013;2013:746749. doi: 10.1155/2013/746749.
  28. Duque JL, Loughlin KR, Adam RM, Kantoff PW, Zurakowski D, Freeman MR Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer. Urology. 1999 Sep;54(3):523-27.
  29. Kodama J, Yoshinouchi M, Seki N, Hongo A, Miyagi Y, Kudo T. Angiogenesis and platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in cervical cancer. Int J Oncol. 1999 Jul;15(1):149-54.
  30. Neitzel LT, Neitzel CD, Magee KL, Malafa MP. Angiogenesis correlates with metastasis in melanoma. Ann Surg Oncol. 1999 Jan-Feb;6(1):70-4.
  31. Shibata MA, Shibata E, Morimoto J, Harada-Shiba M.Therapy with siRNA for Vegf-c but not for Vegf-d suppresses wide-spectrum organ metastasis in an immunocompetent xenograft model of metastatic mammary cancer. 2013 Oct;33(10):4237-47.
  32. Chen J, Zhang J, Liu X, Fang R, Zhao Y, Ma D. Overexpression of fibulin-4 is associated with tumor progression and poor prognosis in patients with cervical carcinoma. Oncol Rep. 2014 Jun;31(6):2601-10. doi: 10.3892/or.2014.3139.
  33. Masola V, Secchi MF, Gambaro G, Onisto M. Heparanase as a target in cancer therapy. Curr Cancer Drug Targets. 2014 Mar;14(3):286-93.
  34. Wang N, Wang QJ, Feng YY, Shang W, Cai M. Overexpression of chemerin was associated with tumor angiogenesis and poor clinical outcome in squamous cell carcinoma of the oral tongue. Clin Oral Investig. 2014 Apr;18(3):997-1004. doi: 10.1007/s00784-013-1046-8.
  35. Lee E, Fertig EJ, Jin K, Sukumar S, Pandey NB, Popel AS.Breast cancer cells condition lymphatic endothelial cells within pre-metastatic niches to promote metastasis. Nat Commun. 2014 Sep 2;5:4715. doi: 10.1038/ncomms5715.
  36. Berta J, Hoda MA, Laszlo V, Rozsas A, Garay T, Torok S, Grusch M, Berger W, Paku S, Renyi-Vamos F, Masri B, Tovari J, Groger M, Klepetko W, Hegedus B, Dome B. Apelin promotes lymphangiogenesis and lymph node metastasis. Oncotarget. 2014 Jun 30;5(12):4426-37.
  37. Lee E, Pandey NB, Popel AS. Pre-treatment of mice with tumor-conditioned media accelerates metastasis to lymph nodes and lungs: a new spontaneous breast cancer metastasis model. Clin Exp Metastasis. 2014 Jan;31(1):67-79. doi: 10.1007/s10585-013-9610-9
  38. Orecchioni S, Gregato G, Martin-Padura I, Reggiani F, Braidotti P, Mancuso P, Calleri A, Quarna J, Marighetti P, Aldeni C, Pruneri G, Martella S, Manconi A, Petit JY, Rietjens M, Bertolini F. Complementary populations of human adipose CD34+ progenitor cells promote growth, angiogenesis, and metastasis of breast cancer. Cancer Res. 2013 Oct 1;73(19):5880-91. doi: 10.1158/0008-5472.CAN-13-0821.
  39. Arapandoni-Dadioti P, Giatromanolaki A, Trihia H, Harris AL, Koukourakis MI. Angiogenesis in ductal breast carcinoma. Comparison of microvessel density between primary tumour and lymph node metastasis. Cancer Lett. 1999 Apr 1;137(2):145-50.
  40. Hakala T, Sand J, Kellokumpu-Lehtinen PL, Huhtala H, Leinonen R, Kholová I.Recurrent thyroid cancers have more peritumoural lymphatic vasculature than nonrecurrent thyroid cancers. Eur J Clin Invest. 2014 Sep;44(9):825-32. doi: 10.1111/eci.12301.
  41. Liu H, Jiang Y, Dai Q, Zhu Q, Wang L, Lu J.Peripheral enhancement of breast cancers on contrast-enhanced ultrasound: correlation with microvessel density and vascular endothelial growth factor expression. Ultrasound Med Biol. 2014 Feb;40(2):293-9. doi: 10.1016/j.ultrasmedbio.2013.10.004.
  42. Mohammed ZM, McMillan DC, Edwards J, Mallon E, Doughty JC, Orange C, Going JJ.The relationship between lymphovascular invasion and angiogenesis, hormone receptors, cell proliferation and survival in patients with primary operable invasive ductal breast cancer. BMC Clin Pathol. 2013 Nov 25;13(1):31. doi: 10.1186/1472-6890-13-31.
  43. Leedy DA, Trune DR, Kronz JD, Weidner N, Cohen JI.Tumor angiogenesis, the p53 antigen, and cervical metastasis in squamous carcinoma of the tongue. Otolaryngol Head Neck Surg. 1994 Oct;111(4):417-22.
  44. Ellis LM, Takahashi Y, Fenoglio CJ, Cleary KR, Bucana CD, Evans DB.Vessel counts and vascular endothelial growth factor expression in pancreatic adenocarcinoma. Eur J Cancer. 1998 Feb;34(3):337-40.
  45. Wang WQ, Liu L, Xu HX, Luo GP, Chen T, Wu CT, Xu YF, Xu J, Liu C, Zhang B, Long J, Tang ZY, Yu XJ. Intratumoral α-SMA enhances the prognostic potency of CD34 associated with maintenance of microvessel integrity in hepatocellular carcinoma and pancreatic cancer. PLoS One. 2013 Aug 5;8(8):e71189. doi: 10.1371/journal.pone.0071189.
  46. Nayak S, Goel MM, Bhatia V, Chandra S, Makker A, Kumar S, Agrawal SP, Mehrotra D, Rath SK. Molecular and phenotypic expression of decorin as modulator of angiogenesis in human potentially malignant oral lesions and oral squamous cell carcinomas. Indian J Pathol Microbiol. 2013 Jul-Sep;56(3):204-10. doi: 10.4103/0377-4929.120366.
  47. Taskiran C, Erdem O, Onan A, Vural C, Arisoy O, Yildiz S, Guner H.Maspin expression in endometrial hyperplasia and carcinoma, and its relation with angiogenesis. Eur J Gynaecol Oncol. 2014;35(2):134-9.
  48. Ito S, Miyashita H, Suzuki Y, Kobayashi M, Satomi S, Sato Y.Enhanced cancer metastasis in mice deficient in vasohibin-1 gene. 2013 Sep 16;8(9):e73931. doi: 10.1371/journal.pone.0073931. eCollection 2013.
  49. Wang HY, Chen Z, Wang ZH, Wang H, Huang LM.Prognostic significance of α5β1-integrin expression in cervical cancer. Asian Pac J Cancer Prev. 2013;14(6):3891-95.
Address for correspondence:
630090, Rossiskaya Federatsiya,
g. Novosibirsk, pr-t. akad. Lavrenteva, 8,
Institut khimicheskoy biologii
i fundamentalnoy meditsinyi SO RAN,
Tsentr novyih meditsinskih tehnologiy,
tel.mob.: 7-913-753-0767,
e-mail: imai@mail.ru,
Maiborodin Igor Valentinovich
Information about the authors:
Maiborodin I.V. MD, professor, a leading researcher of the stem cell laboratory of FSBES "Institute of Chemical Biology and Fundamental Medicine", of SB of RAS.
Krasilnikov S.E. MD, professor of the oncology chair of SBEE HPE "Novosibirsk State Medical University".
Kozjakov A.E. A post-graduate student of the oncology chair of SBEE HPE "Novosibirsk State Medical University".
Babayants E.V. PhD, an applicant for Doctors degree of the oncology chair of SBEE HPE "Novosibirsk State Medical University".
Kulidzhanyan A.P. A post-graduate student of the oncology chair of SBEE HPE "Novosibirsk State Medical University".
Contacts | ©Vitebsk State Medical University, 2007